Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867539-25-000006
Filing Date
2025-12-19
Accepted
2025-12-19 18:14:26
Documents
1
Period of Report
2025-12-18

Document Format Files

Seq Description Document Type Size
1 form4-12192025_111222.html 4  
1 form4-12192025_111222.xml 4 4609
  Complete submission text file 0001867539-25-000006.txt   6062
Mailing Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 811591163 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE B221 #125 REDMOND WA 98053
Business Address
Levin Andrew David (Reporting) CIK: 0001867539 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251588821